Treatments for mutations in acute myeloid leukemia
US12268690B2 · kind B2 · utility
0Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 26, 2019 |
| Grant date | Apr 8, 2025 |
| Priority date | — |
| Expiry date | Jun 8, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to useful methods of treating Acute Myeloid Leukemia (AML) in a human. in the presence of gene mutations.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.